Boots Pharmacist given GPhC Warning after Diazepam Theft
Date of Decision: December 8, 2025
Registrant's Role: Pharmacist
Allegations:
- Removed 8 tablets of 5mg diazepam, a controlled drug, from her workplace without permission or valid reason.
- Initially denied removing the diazepam during an internal investigation and claimed it had been prescribed.
- Admitted to taking the medicine for personal use only after being confronted with witness evidence.
- Had not been prescribed diazepam since 2019, despite claiming otherwise.
Outcome: Warning issued to remain on the register for 12 months.
GPhC Standards Breached:
- Standard 6 – Behave professionally
- Standard 8 – Speak up when things go wrong
Case Summary
Allegations
The case involves a pharmacist who was employed at a Boots Pharmacy at the time of the incident. On or around 10 July 2024, she removed eight tablets of 5mg diazepam—a controlled drug—from the pharmacy without authorisation or a valid prescription. Diazepam, a benzodiazepine with potential for dependence and abuse, is tightly regulated and requires careful handling within any pharmacy setting. The unauthorised removal of such medication represents a significant breach of professional and legal obligations.
When questioned during an internal investigation, the registrant initially denied taking the medication and falsely claimed she had a valid prescription. It was only after two witness statements were presented during the same meeting that she admitted to taking the tablets for personal use, citing the need to manage pain from a health condition.
Continue Reading the Full Case
Create a free account or log in to access the complete case summary.
- Full allegations considered by the GPhC
- Panel findings and reasoning
- Outcome of the investigation
- Sanctions considered and imposed on the Pharmacist
- Key professional learning points
Original Case Document
View the Full Determination Document
The original determination transcript is available to registered users.
- Download the official GPhC determination
- Full hearing transcript
- Detailed findings of fact
- Sanction reasoning
- Details of the pharmacy professionals involved